Holen Sie sich die Stockscreener-App
1.55
72.42%
0.6511
Handel nachbörslich:
1.45
-0.10
-6.45%
Schlusskurs vom Vortag:
$0.899
Offen:
$1.82
24-Stunden-Volumen:
140.71M
Relative Volume:
27.05
Marktkapitalisierung:
$9.03M
Einnahmen:
$14.64M
Nettoeinkommen (Verlust:
$-13.74M
KGV:
-0.2132
EPS:
-7.27
Netto-Cashflow:
$-5.04M
1W Leistung:
+50.49%
1M Leistung:
+130.53%
6M Leistung:
+154.06%
1J Leistung:
+205.69%
1-Tages-Spanne:
$1.50
$1.90
1-Wochen-Bereich:
$0.8651
$1.90
52-Wochen-Spanne:
$0.44
$1.90
Novabay Pharmaceuticals Inc Stock (NBY) Company Profile
Firmenname
Novabay Pharmaceuticals Inc
Sektor
Branche
Telefon
510-899-8800
Adresse
2000 Powell Street, Suite 1150, Emeryville, CA
Vergleichen Sie NBY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NBY
Novabay Pharmaceuticals Inc
|
1.55 | 5.24M | 14.64M | -13.74M | -5.04M | -7.27 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Novabay Pharmaceuticals Inc Stock (NBY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2019-09-18 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2018-07-06 | Bestätigt | H.C. Wainwright | Buy |
| 2017-11-15 | Bestätigt | Laidlaw | Buy |
| 2017-06-05 | Eingeleitet | ROTH Capital | Buy |
| 2017-03-27 | Eingeleitet | Laidlaw | Buy |
| 2017-02-06 | Eingeleitet | Rodman & Renshaw | Buy |
| 2016-03-07 | Herabstufung | Maxim Group | Buy → Hold |
| 2015-12-14 | Bestätigt | Maxim Group | Buy |
| 2015-04-30 | Fortgesetzt | Maxim Group | Buy |
| 2013-03-06 | Eingeleitet | Ascendiant Capital Markets | Strong Buy |
| 2008-01-03 | Eingeleitet | Dawson James | Speculative Buy |
Alle ansehen
Novabay Pharmaceuticals Inc Aktie (NBY) Neueste Nachrichten
Predicting NovaBay Pharmaceuticals Inc. trend using moving averagesJuly 2025 Gainers & Low Drawdown Momentum Trade Ideas - Newser
Stocks to Watch Today : Nvidia, CrowdStrike, DSS Inc., NovaBay Pharma, Kohl’s Corporation - Eurasia Business News
How to build a custom watchlist for NovaBay Pharmaceuticals Inc.Gold Moves & Smart Swing Trading Techniques - Newser
NovaBay, MongoDB, And Jinxin Pop On News And Results - Finimize
Top Midday Gainers - MarketScreener
NovaBay’s Dramatic Stock Rise: What’s Next? - StocksToTrade
NovaBay Stock Surge: Buy or Wait? - timothysykes.com
Advanced analytics toolkit walkthrough for NovaBay Pharmaceuticals Inc.Weekly Market Outlook & Target Return Focused Stock Picks - Newser
Why Did Novabay Stock Soar 56.84%? - AInvest
Is NovaBay Pharmaceuticals Inc. stock entering bullish territoryAnalyst Downgrade & Safe Capital Preservation Plans - Newser
NovaBay Pharmaceuticals Stock Soars 48% After Hours, Following Special Dividend Declaration - inkl
Combining machine learning predictions for NovaBay Pharmaceuticals Inc.Trade Risk Summary & Long-Term Safe Investment Ideas - Newser
Using data tools to time your NovaBay Pharmaceuticals Inc. exitEarnings Recap Report & Fast Entry Momentum Alerts - Newser
Screener Results Flag NovaBay Pharmaceuticals Inc. as Oversold getLinesFromResByArray error: size == 0 - newsyoung.net
NovaBay Pharma Announces Special Cash Dividend - TipRanks
NovaBay's $0.80 Special Dividend: A Strategic Catalyst for Shareholder Value Amid Restructuring - AInvest
NovaBay Pharmaceuticals Declares Special Cash Dividend of $0.80 a Share, Payable Sept. 29 to Holders of Record Sept. 15 - MarketScreener
Novabay Pharmaceuticals announces one-time special cash dividend of $0.80 per share - MarketScreener
Price action breakdown for NovaBay Pharmaceuticals Inc.Dollar Strength & Low Drawdown Momentum Ideas - Newser
Can technical indicators confirm NovaBay Pharmaceuticals Inc.’s reversal2025 Technical Overview & Safe Swing Trade Setups - Newser
Insider Buy: What’s the MACD signal for NovaBay Pharmaceuticals Inc.July 2025 Momentum & Reliable Breakout Stock Forecasts - sundaytimes.kr
Order flow analysis tools used on NovaBay Pharmaceuticals Inc.Weekly Trend Summary & Low Risk High Win Rate Stock Picks - Newser
Is now a turning point for NovaBay Pharmaceuticals Inc.July 2025 Recap & AI Based Trade Execution Alerts - Newser
Signal strength of NovaBay Pharmaceuticals Inc. stock in tech scannersJuly 2025 Sector Moves & Stepwise Trade Execution Plans - Newser
What is NovaBay Pharmaceuticals Inc. s debt to equity ratio2025 Historical Comparison & Risk Managed Investment Entry Signals - theviewers.co.kr
Is NovaBay Pharmaceuticals Inc. a turnaround story2025 Stock Rankings & Smart Allocation Stock Tips - theviewers.co.kr
Can NovaBay Pharmaceuticals Inc. rally from current levelsJuly 2025 Sector Moves & Reliable Entry Point Alerts - Newser
Investor Alert: NBY, OP, STAI, PNPNFStocks Under $1 Complete Watch List Inside - MarketScreener
NovaBay Pharmaceuticals Enters $6M Securities Purchase Agreement, Stock Trades Higher - AInvest
What’s next for NovaBay Pharmaceuticals Inc. stock priceJuly 2025 Big Picture & Safe Capital Growth Trade Ideas - Newser
NovaBay Stock Is Trading Higher Wednesday: What's Going On?NovaBay Pharmaceuticals (AMEX:NBY) - Benzinga
Analyzing NovaBay Pharmaceuticals Inc. with multi timeframe chartsEarnings Summary Report & Intraday High Probability Setup Alerts - Newser
Novabay's 67.5% Surge: A Lifeline Investment Ignites Biotech Drama - AInvest
NovaBay’s Rise: Future Growth or Bubble? - StocksToTrade
Novabay Pharmaceuticals, Inc. shares rise over 100.0%, currently trading at $1.23 - AInvest
What Does This Mean for NovaBay Pharmaceuticals? - timothysykes.com
NovaBay Pharmaceuticals Secures $6 Million Investment, Shares Surge - AInvest
NovaBay Names New CEO, Rocket Soars As FDA Lifts Clinical Hold, Celldex Plunges, Soligenix On Watch - RTTNews
NovaBay Pharmaceuticals stock surges 60% after securing $6 million deal with private investor David Lazar, who takes on role of CEO. - AInvest
NovaBay Stock Soars 65.67% on $6M Investment - AInvest
NovaBay Pharmaceuticals Reverses Liquidation Path with $6 Million Investment Deal and Leadership Changes - AInvest
NovaBay Pharma Appoints New CEO Amid Strategic Shift - MSN
NovaBay Pharmaceuticals Soars 66% In Pre-Market On $6 Million Investment Deal, CEO Appointment - Benzinga
NovaBay Pharmaceuticals shares rise 81.67% premarket after entering a $6 million securities purchase agreement with David E. Lazar. - AInvest
Can volume confirm reversal in NovaBay Pharmaceuticals Inc.Trade Analysis Report & Low Drawdown Investment Strategies - Newser
Historical volatility pattern of NovaBay Pharmaceuticals Inc. visualized2025 Winners & Losers & Technical Pattern Based Buy Signals - Newser
NovaBay Pharmaceuticals Secures $6M Investment from David Lazar through Securities Purchase Agreement - AInvest
NovaBay's $6M Lazar Transaction and Strategic Turnaround Potential: A Deep Dive into Capital Restructuring and Shareholder Value Creation in Distressed Biotech Plays - AInvest
NovaBay's Strategic Turnaround: A $6M Lifeline and Leadership Shift Signal New Value Propositions - AInvest
NovaBay jumps after $6 million investment, new CEO - TradingView
NovaBay Pharmaceuticals Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar - The Manila Times
Finanzdaten der Novabay Pharmaceuticals Inc-Aktie (NBY)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.98%
8.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):